Minimal cardiac electro-physiological activity of alprenoxime, a site-activated ocular β-blocker, in dogs
Authors:
- Nicholas BodorNBNicholas Bodor
- 1 February 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 56 (14) , 1207-1213
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Reversed-phase high-performance liquid chromatography of ketoxime analogues of β-adrenergic blockersJournal of Chromatography A, 1991
- Cardiac electrophysiologic effects of adaprolol maleate, a new β-blocker, in closed chest dogsLife Sciences, 1991
- Improved Delivery Through Biological Membranes. LVI. Pharmacological Evaluation of Alprenoxime—A New Potential Antiglaucoma AgentPharmaceutical Research, 1991
- Soft drugs. 7. Soft .beta.-blockers for systemic and ophthalmic useJournal of Medicinal Chemistry, 1988
- Improved delivery through biological membranes. 26. Design, synthesis, and pharmacological activity of a novel chemical delivery system for .beta.-adrenergic blocking agentsJournal of Medicinal Chemistry, 1988
- Novel ‘soft’ β-blockers as potential safe antiglaucoma agentsCurrent Eye Research, 1988
- Bronchial beta-adrenoceptor blockade following eyedrops of timolol and its isomer L-714,465 in normal subjects.British Journal of Clinical Pharmacology, 1985
- Effects of Topical Betaxolol, Timolol, and Placebo on Pulmonary Function in Asthmatic BronchitisAmerican Journal of Ophthalmology, 1984
- Adrenergic blocking agents. A double-blind trial in the treatment of the eye signs of thyroid disorders.British Journal of Ophthalmology, 1968
- Propranolol as ocular hypotensive agent.British Journal of Ophthalmology, 1967